|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/45 | |
| A61K 31/506 | |||
| A61K 31/517 | |||
| C07D 401/04 |
| (11) | Number of the document | 2943201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14737860.8 |
| Date of filing the European patent application | 2014-01-14 | |
| (97) | Date of publication of the European application | 2015-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/011440 |
| Date | 2014-01-14 |
| (87) | Number | WO 2014/110558 |
| Date | 2014-07-17 |
| (30) | Number | Date | Country code |
| 201361752055 P | 2013-01-14 | US | |
| 201361786024 P | 2013-03-14 | US |
| (72) |
DEWITT, Sheila, US
|
| (73) |
Deuterx, LLC,
300 Brickstone Square, Suite 201, Andover, MA 01810,
US
|
| (54) | 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES |
| 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES |